Trial Profile
An Investigator-initiated, Open-label, Pilot Study to Evaluate the Efficacy and Safety of Denosumab for the Treatment of Low Bone Mineral Density Post Renal Transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 09 Feb 2016 New trial record